Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non–Small Cell Lung Cancer

Mitchell S. von Itzstein, Timothy F. Burns, Jonathan E. Dowell, Leora Horn, D. Ross Camidge, Sally J. York, Keith D. Eaton, Kelly Kyle, Farjana Fattah, Jialiang Liu, Hong Mu-Mosley, Arjun Gupta, Urooba Nadeem, Ang Gao, Song Zhang, David E. Gerber

Research output: Contribution to journal › Article › peer-review

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science